Jane Street’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Sell
30,400
-1,500
-5% -$106K ﹤0.01% 5022
2025
Q4
$2.42M Buy
31,900
+22,700
+247% +$1.65M ﹤0.01% 4438
2025
Q3
$565K Buy
+9,200
New +$479K ﹤0.01% 7598
2025
Q2
Sell
-4,900
Closed -$250K 10617
2025
Q1
$250K Sell
4,900
-138,300
-97% -$6.9M ﹤0.01% 8108
2024
Q4
$6.46M Buy
143,200
+136,100
+1,917% +$5.82M ﹤0.01% 2350
2024
Q3
$263K Buy
+7,100
New +$238K ﹤0.01% 8237
2023
Q4
Sell
-401,800
Closed -$9M 9681
2023
Q3
$9M Buy
401,800
+388,600
+2,944% +$14.5M ﹤0.01% 1888
2023
Q2
$537K Buy
13,200
+7,500
+132% +$367K ﹤0.01% 6210
2023
Q1
$276K Sell
5,700
-11,700
-67% -$535K ﹤0.01% 7332
2022
Q4
$664K Buy
+17,400
New +$723K ﹤0.01% 5661
2022
Q3
Sell
-10,600
Closed -$425K 10289
2022
Q2
$425K Buy
+10,600
New +$372K ﹤0.01% 7023
2021
Q3
Sell
-6,300
Closed -$266K 10564
2021
Q2
$266K Buy
+6,300
New +$270K ﹤0.01% 8361
2020
Q4
Sell
-8,500
Closed -$397K 7984
2020
Q3
$397K Buy
+8,500
New +$418K ﹤0.01% 5502
2017
Q4
Sell
-103,800
Closed -$2.08M 5061
2017
Q3
$2.08M Buy
+103,800
New +$2.03M 0.01% 1562
2017
Q1
Sell
-16,700
Closed -$182K 4573
2016
Q4
$182K Buy
+16,700
New +$175K ﹤0.01% 3763
2015
Q4
Sell
-74,600
Closed -$1.99M 4359
2015
Q3
$1.99M Buy
+74,600
New +$3.19M 0.01% 988

Other funds holding PTCT

Jane Street's PTCT Position: Q1 2026 in Review

Jane Street sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 3,925 shares — an estimated $278K sold.

Jane Street first reported a position in PTCT in Q2 2014 and held it in 35 quarters. The position peaked at $22.5M in Q4 2023. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Jane Street reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 3,925 PTC Therapeutics shares in Q1 2026, an estimated $278K.
  • Jane Street first reported a position in PTC Therapeutics in Q2 2014 and held it in 35 quarters.
  • Jane Street's PTC Therapeutics position peaked at $22.5M in Q4 2023.
  • 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.